Immune checkpoint inhibitor-related T-cell-mediated rejection increases the risk of perioperative graft loss after liver transplantation
IrTCMR is associated with severe pathological features, increased resistance to treatment, and higher graft loss in adult liver transplant recipients.
Authors
- Li Pang (ORCID: https://orcid.org/0000-0002-7163-6255)
- Fapeng Zhang
- Tao Ding (ORCID: https://orcid.org/0000-0002-5744-3801)
- Yan‐Fang Ye (ORCID: https://orcid.org/0000-0002-5800-8377)
- Wenrui Wu (ORCID: https://orcid.org/0000-0003-1773-5823)
- Lei‐Bo Xu (ORCID: https://orcid.org/0000-0002-9236-5343)
- Guangxiang Gu (ORCID: https://orcid.org/0000-0001-9168-7415)
- Chao Liu
- Kaixun Huang (ORCID: https://orcid.org/0000-0001-7498-4397)
- Kun He (ORCID: https://orcid.org/0000-0002-1510-860X)
- Haoming Lin (ORCID: https://orcid.org/0000-0001-7311-4832)
- Yutian Lin
- Xinjun Lu (ORCID: https://orcid.org/0000-0002-7643-0854)
- Kwan Man
Institutions
- Sun Yat-sen University (CN)
- Chinese University of Hong Kong (HK)
- Sun Yat-sen Memorial Hospital (CN)
- Zhongshan People's Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1097/cm9.0000000000003669
- Citations
- 3
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 6.02